World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
30634
World Ranking
2368
National Ranking
1135

David B. Lewis publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David B. Lewis sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 219 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

David B. Lewis D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David B. Lewis sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

David B. Lewis is affiliated with Stanford University in the United States. Their research primarily focuses on medicine with significant contributions to immunology and microbiology.

The scientist's recent publications cover a range of topics within infectious diseases, immunology, and genetic engineering. Notable papers include:

  • "COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives," 2020, published in Nature Reviews Cardiology
  • "Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza," 2020, published in Cell
  • "Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects," 2021, published in Journal of Allergy and Clinical Immunology
  • "Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro," 2022, published in Nature Communications
  • "Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza," 2020, published in bioRxiv (Cold Spring Harbor Laboratory)

Their collaboration network includes frequent co-authorship with researchers such as Yaël Gernez, Kenneth I. Weinberg, Ami J. Shah, Elisabeth G. Hoyte, and Alice Bertaina.

David B. Lewis has published frequently in several venues. Among the most common are:

  • Journal of Allergy and Clinical Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Journal of Crohn's and Colitis
  • Journal of Human Immunity

Their main fields of study encompass:

  • Medicine
  • Immunology and Microbiology

Subfields of study include:

  • Immunology
  • Infectious Diseases
  • Epidemiology
  • Genetics
  • Hematology

The scientist's research topics cover:

  • Immunodeficiency and Autoimmune Disorders
  • SARS-CoV-2 and COVID-19 Research
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Blood disorders and treatments
  • CRISPR and Genetic Engineering
  • Hematopoietic Stem Cell Transplantation

Best Publications

  • Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

    Ash A. Alizadeh;Michael B. Eisen;R. Eric Davis;Izidore S. Lossos

  • COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives.

    Masataka Nishiga;Dao Wen Wang;Yaling Han;David B. Lewis

  • Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice.

    Baohua Zhou;Michael R Comeau;Thibaut De Smedt;H Denny Liggitt

  • An immune clock of human pregnancy.

    Nima Aghaeepour;Edward A. Ganio;David Mcilwain;Amy S. Tsai

  • Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.

    Timothy R. Abbott;Girija Dhamdhere;Yanxia Liu;Xueqiu Lin

  • A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40phox and selective defects in neutrophil NADPH oxidase activity

    Juan D. Matute;Andres A. Arias;Nicola A. M. Wright;Iwona Wrobel

  • Revisiting Human IL-12Rβ1 Deficiency: A Survey of 141 Patients From 30 Countries

    Ludovic de Beaucoudrey;Arina Samarina;Arina Samarina;Arina Samarina;Jacinta Bustamante;Jacinta Bustamante;Aurélie Cobat;Aurélie Cobat

  • Bone Marrow NK1.1− and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host Disease

    Defu Zeng;David Lewis;Sussan Dejbakhsh-Jones;Fengshuo Lan

  • Proliferative and nonproliferative lesions of the rat and mouse respiratory tract.

    Roger Renne;Amy Brix;Jack Harkema;Ron Herbert

  • Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines.

    Xiao-Song He;Tyson H. Holmes;Caiqiu Zhang;Kutubuddin Mahmood

  • The importance of leukotrienes in airway inflammation in a mouse model of asthma.

    William R. Henderson;David B. Lewis;Richard K. Albert;Yu Zhang

  • Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies.

    C B Wilson;J Westall;L Johnston;D B Lewis

  • Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells.

    D B Lewis;C C Yu;J Meyer;B K English

  • Toll-Like Receptor 4 Is Required for Optimal Development of Th2 Immune Responses: Role of Dendritic Cells

    Karim Dabbagh;Martin E. Dahl;Pamela Stepick-Biek;David B. Lewis

  • Novel protein-tyrosine kinase gene (hck) preferentially expressed in cells of hematopoietic origin.

    S F Ziegler;J D Marth;D B Lewis;R M Perlmutter

  • Toll-like receptors and T-helper-1/T-helper-2 responses.

    Karim Dabbagh;David B. Lewis

  • Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells

    Martin E Dahl;Karim Dabbagh;Karim Dabbagh;Denny Liggitt;Sung Kim

  • Cutting Edge: Decreased Accumulation and Regulatory Function of CD4+CD25high T Cells in Human STAT5b Deficiency

    Aileen C. Cohen;Kari C. Nadeau;Wenwei Tu;Vivian Hwa

  • Progression of ventricular wall thickening after liver transplantation for familial amyloidosis.

    Simon W. Dubrey;Ravin Davidoff;Martha Skinner;Peter Bergethon

  • Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: Results of the first 2 years

    Antonia Kwan;Joseph A. Church;Morton J. Cowan;Rajni Agarwal

  • Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response.

    Y. U. Zhang;Wayne J E Lamm;Richard K. Albert;Emil Y. Chi

  • Persistent and Selective Deficiency of CD4+ T Cell Immunity to Cytomegalovirus in Immunocompetent Young Children

    Wenwei Tu;Sharon Chen;Margaret Sharp;Corry Dekker

Frequent Co-Authors

Christopher B. Wilson
Christopher B. Wilson Bill & Melinda Gates Foundation
Wenwei Tu
Wenwei Tu University of Hong Kong
Satoshi Minoshima
Satoshi Minoshima University of Utah
Garry P. Nolan
Garry P. Nolan Stanford University
Roger M. Perlmutter
Roger M. Perlmutter University of Washington
William F. Fearon
William F. Fearon Stanford University
David K. Stevenson
David K. Stevenson Stanford University
Ann M. Arvin
Ann M. Arvin Stanford University
Yu-Lung Lau
Yu-Lung Lau University of Hong Kong
Steven F. Ziegler
Steven F. Ziegler Virginia Mason Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many students transition into nursing roles, where understanding the immune system is crucial. Accelerated routes like accelerated FNP programs offer a fast track to becoming a Family Nurse Practitioner, blending clinical expertise with specialized knowledge.

Non-nurses looking to enter the healthcare field can benefit from online RN programs for non nurses, providing flexible pathways into registered nursing. These programs often emphasize foundational biology, including immunology principles, preparing graduates for patient care.

For those seeking simpler admissions processes, exploring absn programs with high acceptance rates can be an effective way to advance nursing education rapidly. Similarly, easy LPN programs to get into offer accessible entry points into licensed practical nursing, a role often intertwined with immune-related patient care.

Choosing the right program depends on your career goals, prior education, and interest in immunology's role within healthcare. These online options provide flexible, accelerated, and accessible paths to help you make an impact in this vital field.

Best Scientists Citing David B. Lewis

Trending Scientists

Recently Published Articles